Tuesday, June 23, 2020
AngioDynamics to Report Fiscal 2020 Fourth Quarter and Full-Year Financial Results on July 16, 2020
LATHAM, N.Y. --(BUSINESS WIRE)--Jun. 23, 2020-- AngioDynamics, Inc. (NASDAQ: ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, peripheral vascular disease, and oncology, today announced that it will report financial results for the fourth quarter and...

  Monday, June 8, 2020
AngioDynamics to Participate in a Virtual Fireside Chat at the Raymond James Human Health Innovation Conference
LATHAM, N.Y. --(BUSINESS WIRE)--Jun. 8, 2020-- AngioDynamics, Inc. (NASDAQ: ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, peripheral vascular disease, and oncology, today announced that Jim Clemmer , President and Chief Executive Officer, and...

  Thursday, May 7, 2020
AngioDynamics to Present at the UBS Virtual Global Healthcare Conference
LATHAM, N.Y. --(BUSINESS WIRE)--May 7, 2020-- AngioDynamics, Inc. (NASDAQ: ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, peripheral vascular disease, and oncology, today announced that Jim Clemmer , President and Chief Executive Officer, and...

  Tuesday, April 7, 2020
AngioDynamics Reports Fiscal 2020 Third Quarter Financial Results
Fiscal 2020 Third Quarter Highlights Net sales of $69.8 million increased 6.5% compared to the prior-year quarter Gross margin declined 40 basis points to 57.8% year over year GAAP loss per share of $0.15 ; adjusted earnings per share of $0.01 Launched PATHFINDER I Registry to evaluate performance...

  Tuesday, March 10, 2020
AngioDynamics to Report Fiscal 2020 Third Quarter Financial Results on April 7, 2020
LATHAM, N.Y. --(BUSINESS WIRE)-- AngioDynamics, Inc. (NASDAQ: ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, peripheral vascular disease, and oncology, today announced that it will report financial results for the third quarter of fiscal year 2020...

  Thursday, February 27, 2020
AngioDynamics to Present at Two Investor Conferences in March
LATHAM, N.Y. --(BUSINESS WIRE)-- AngioDynamics, Inc. (NASDAQ: ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, peripheral vascular disease, and oncology, today announced that it will present at the following two investor conferences in March:...

  Thursday, February 6, 2020
AngioDynamics Appoints Stephen Trowbridge Executive Vice President and Chief Financial Officer
LATHAM, N.Y. --(BUSINESS WIRE)--Feb. 6, 2020-- AngioDynamics, Inc. (NASDAQ: ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, peripheral vascular disease, and oncology, today announced that it has appointed Stephen Trowbridge to the role of Executive...

  Thursday, January 16, 2020
AngioDynamics Launches PATHFINDER I Registry to Evaluate Performance and Clinical Outcomes of the AURYON™ Atherectomy System
LATHAM, N.Y. --(BUSINESS WIRE)--Jan. 16, 2020-- AngioDynamics, Inc. (NASDAQ: ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, peripheral vascular disease, and oncology, today announced the launch of the PATHFINDER I: Post-Market Registry (PATHFINDER...

  Tuesday, January 7, 2020
AngioDynamics Reports Fiscal 2020 Second Quarter Financial Results
Fiscal 2020 Second Quarter Highlights Net sales of $70.0 million , flat compared to the prior-year quarter Gross margin increased 140 basis points year over year to 59.3% GAAP loss per share of $0.07 ; adjusted earnings per share of $0.06 Announces the acquisition of C3 Wave PICC tip location...

  Monday, January 6, 2020
AngioDynamics to Present at the J.P. Morgan Healthcare Conference
LATHAM, N.Y. --(BUSINESS WIRE)--Jan. 6, 2020-- AngioDynamics, Inc. (NASDAQ: ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, peripheral vascular disease, and oncology, today announced that Jim Clemmer , President and Chief Executive Officer, and...

  Tuesday, December 10, 2019
AngioDynamics to Report Fiscal 2020 Second Quarter Financial Results on January 7, 2020
LATHAM, N.Y. --(BUSINESS WIRE)--Dec. 10, 2019-- AngioDynamics, Inc. (NASDAQ: ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, peripheral vascular disease, and oncology, today announced that it will report financial results for the second quarter of...

  Tuesday, October 22, 2019
AngioDynamics Announces Departure of CFO and Appointment of Interim CFO
LATHAM, N.Y. --(BUSINESS WIRE)--Oct. 22, 2019-- AngioDynamics, Inc. (NASDAQ: ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, peripheral vascular disease, and oncology, today announced that Michael C. Greiner , Executive Vice President and Chief...

  Thursday, October 3, 2019
AngioDynamics Reports Fiscal 2020 First Quarter Financial Results
  Fiscal 2020 First Quarter Highlights         Net sales of $66.0 million , an increase of 3.3% year over year       Gross margin increased 170 basis points year over year to 57.9%       GAAP loss per share of $0.03 ; adjusted earnings per share of $0.08         LATHAM, N.Y. --(BUSINESS WIRE)--Oct....

  Thursday, October 3, 2019
AngioDynamics Acquires Eximo Medical, Ltd. and its Innovative 355nm Laser Atherectomy Technology
  LATHAM, N.Y. --(BUSINESS WIRE)--Oct. 3, 2019-- AngioDynamics, Inc. (NASDAQ: ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, peripheral vascular disease, and oncology, today announced that it has acquired Eximo Medical, Ltd....

  Monday, September 9, 2019
AngioDynamics Awarded Premier’s Nationally Outsourced Implantable Infusion Port Agreement
LATHAM, N.Y. --(BUSINESS WIRE)--Sep. 9, 2019-- AngioDynamics, Inc. (NASDAQ: ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, peripheral vascular disease, and oncology, today announced that the Company has been awarded a dual-source group purchasing...